Compounds for the Treatment of Kinase-Dependent Disorders

The present invention relates to compounds that modulate cellular activities such as proliferation, differentiation, programmed cell death, migration, and chemoinvasion, by modulating protein kinase enzymatic activity, and compositions thereof, and methods of using such compounds.

Saved in:
Bibliographic Details
Main Authors Jiang, Faming, Tso, Kin, Bannen, Lynne Canne, Wei, Xu
Format Patent
LanguageEnglish
Published 24.03.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to compounds that modulate cellular activities such as proliferation, differentiation, programmed cell death, migration, and chemoinvasion, by modulating protein kinase enzymatic activity, and compositions thereof, and methods of using such compounds.
Bibliography:Application Number: US202017425661